Biosimilars White Paper
The availability of biosimilars worldwide offers the promise of increased patient access to biologic therapies and considerable health care cost savings. In order to better understand knowledge and attitudes about biosimilars, The France Foundation conducted an online survey of a diverse group of health care professionals in the US.
 |
Conducted just before the first biosimilar approval in the US, this white paper includes data on:
|
